XML 98 R44.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Risk Management and Derivatives (Tables)

12 Months Ended

Dec. 31, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of fair value of derivative financial instruments as well as their classification on Consolidated Balance Sheets

The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the consolidated balance sheets as of December 31, 2019 and 2018 ($ in thousands)⁽¹⁾:

		Derivative Assets						Derivative Liabilities
As of December 31, 2019		Balance Sheet Location		Fair Value				Balance Sheet Location		Fair Value
Derivatives Designated in Hedging Relationships
Interest rate swaps		Deferred expenses and other assets, net		$	114			Accounts payable, accrued expenses and other liabilities		$	8,680
Total				$	114					$	8,680
As of December 31, 2018
Derivatives Designated in Hedging Relationships
Interest rate swaps		Deferred expenses and other assets, net		$	3,669			Accounts payable, accrued expenses and other liabilities		$	10,244
Total				$	3,669					$	10,244

____________________________________________________________________________

(1) Over the next 12 months, the Company expects that $5.1 million related to cash flow hedges will be reclassified from "Accumulated other comprehensive income (loss)" as an increase to interest expense.

Schedule of derivative financial instruments on Consolidated Statements of Operations

The tables below present the effect of the Company's derivative financial instruments, including the Company's share of derivative financial instruments at certain of its equity method investments, in the consolidated statements of operations and the consolidated statements of comprehensive income (loss) ($ in thousands):

Derivatives Designated in Hedging Relationships		Location of Gain (Loss) When Recognized in Income		Amount of Gain (Loss) Recognized in Accumulated Other Comprehensive Income				Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income into Earnings
For the Year Ended December 31, 2019
Interest rate swaps(1)		Interest expense		$	(21,165	)		$	(1,861	)
Interest rate swaps		Earnings from equity method investments		(21,417		)		(184		)
For the Year Ended December 31, 2018
Interest rate swaps		Interest expense		(12,963		)		(388		)
Interest rate swaps		Earnings from equity method investments		(1,736		)		20
For the Year Ended December 31, 2017
Interest rate cap		Earnings from equity method investments		(16		)		(16		)
Interest rate swaps		Interest expense		495				339
Interest rate swap		Earnings from equity method investments		368				(285		)
Foreign exchange contracts		Earnings from equity method investments		(352		)		—

______________________________________________________________

(1) For the year ended December 31, 2019, $4.3 million of the loss recognized in accumulated other comprehensive income was attributable to a noncontrolling interest.

		Location of Gain or (Loss) Recognized in Income		Amount of Gain or (Loss) Recognized in Income
Derivatives not Designated in Hedging Relationships(1)				For the Year Ended December 31, 2017
Interest rate cap		Other expense		$	6
Foreign exchange contracts		Other expense		(970		)

____________________________________________________________________________

(1)

The Company did not have any derivatives not designated in hedging relationships during the years ended December 31, 2019 and 2018.

X

- References

No definition available.

+ Details

Name:	us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4E
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959

+ Details

Name:	us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959

+ Details

Name:	us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration